COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 332: Articles 3311-3320  | Next

Safety and immunogenicity of COReNAPCIN(R), a SARS-CoV-2 mRNA vaccine; a randomized, double-blind, placebo-controlled phase 1 clinical trial
Salehi, M., Alavi Darazam, I., Nematollahi, A., Alimohammadi, M., Pouya, S., Alimohammadi, R., Khajavirad, N., Porgoo, M., Sedghi, M., Sepahi, M. M., Azimi, M., Hosseini, H. H., Hashemi, S. M., Dehghanizadeh, S., Khoddami, V.
10.1101/2023.11.01.23297898 — Posted: 2023-11-02
Phylogenetic meta-analysis of chronic SARS-CoV-2 infections in immunocompromised patients shows no evidence of elevated evolutionary rates
Oversti, S., Gaul, E., Jensen, B.-E. O., Kuhnert, D.
10.1101/2023.11.01.565087 — Posted: 2023-11-02
Gods Lockdown: the effect of the April 2022 Colorado low blizzard on SARS-Cov-2 transmission in the midwest United States
Strobel, S., Daly, M.
10.1101/2023.11.01.23297908 — Posted: 2023-11-02
Patient phenotypes and their relation to TNFα signaling and immune cell composition in critical illness and autoimmune disease
Krishna, V., Banie, H., Conceicao-Neto, N., Murata, Y., Verbrugge, I., Trifonov, V., Martinez, R., Murali, V., Lee, Y.-c., May, R. D., Najera, I., Fowler, A., Li, C. K. F.
10.1101/2023.10.30.564631 — Posted: 2023-11-01
SARS-CoV-2 infection leads to sustained testicular injury and functional impairments in K18 hACE2 mice
Giannakopoulos, S., Ward, M. A., Bakse, J., Pak, J. H., Nerurkar, V. R., Tallquist, M. D., Verma, S.
10.1101/2023.10.31.565042 — Posted: 2023-11-01
Pervasive aggregation and depletion of host and viral proteins in response to cysteine-reactive electrophilic compounds
Julio, A. R., Shikwana, F., Truong, C., Burton, N. R., Dominguez, E., Turmon, A., Cao, J., Backus, K.
10.1101/2023.10.30.564067 — Posted: 2023-11-01
Stability of DNA-Methylation Profiles of Biological Aging in Children and Adolescents
deSteiguer, A. J., Raffington, L., Sabhlok, A., Tanksley, P. T., Harden, K. P., Tucker-Drob, E. M.
10.1101/2023.10.30.564766 — Posted: 2023-11-01
Assessment of The Broad-Spectrum Host Targeting Antiviral Efficacy of Halofuginone Hydrobromide in Human Airway, Intestinal and Brain Organoid Models.
Garcia-Rodriguez, I., Moreni, G., Capendale, P. E., Aknouch, I., Mulder, L. A., Johannesson, N., Vieira de Sa, R., Freeze, E., van Eijk, H., Koen, G., Wolthers, K. C., Pajkrt, D., Sridhar, A., Calitz, C.
10.1101/2023.11.01.565121 — Posted: 2023-11-01
Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine
Komori, M., Morey, A. L., Quinones-Molina, A. A., Fofana, J., Romero, L., Peters, E., Matsuda, K., Gummuluru, S., Smith, J. F., Akahata, W., Akiyama, H.
10.1101/2023.11.01.565056 — Posted: 2023-11-01
SARS-CoV-2 spike protein induces the cytokine release syndrome by stimulating T cells to produce more IL-2
Niu, C., Liang, T., Chen, Y., Zhu, S., Zhou, L., Chen, N., Qian, L., Wang, Y., Li, M., Zhou, X., Cui, J.
10.1101/2023.11.01.565098 — Posted: 2023-11-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).